Our Story
Since June 18, 2020, USPA has been dedicated to advancing medical research. We have participated in studies focused on NASH/MASH, Crohn’s Disease, Ulcerative Colitis, Gastroparesis, and COPD, among others. Our work spans multiple therapeutic areas, including respiratory, gastroenterology, cardiology, psychiatry, and dermatology, helping to drive innovation and improve patient outcomes.










